TransMedics Stock Has a Post-Holiday Test — The Next Catalyst Is Already on the Calendar
TransMedics Group shares traded at $68.94 in premarket Tuesday, up 0.2% after the Memorial Day break, valuing the company near $2.5 billion. The move followed a May earnings report showing 21% revenue growth but a sharp drop in net income to $7.3 million. No new company news was posted after May 21. Wall Street analysts cut price targets earlier in May but mostly kept positive ratings.